Phase I study of paclitaxel (P) combined with 14-day topotecan (T) Continuous IV (CIV) infusion in previously treated and untreated patients (PTS)

Autor:	A. Chachoua, Joan Sorich, C. Wasserheit, B. Taubes, Howard S. Hochster, S. Arbuck, A. Friedberg, J. Speyer
Rok vydání:	1997
Předmět:	Cancer Research chemistry.chemical_compound Oncology Paclitaxel chemistry business.industry medicine Topotecan Pharmacology Previously treated business medicine.drug Phase i study
Zdroj:	European Journal of Cancer. 33:S250
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(97)86041-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4405013efb7e9463bd29c64bb7f6bd78 https://doi.org/10.1016/s0959-8049(97)86041-8 Zobrazit plný text záznamu Full Text from ScienceDirect